CLINICAL_TRIALS
trial_result
· 2019-01-24
Clinical Trial Update: Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"
Summary
The Pioglitazone Special Drug Use Surveillance trial evaluating metabolic syndrome in patients with Type 2 Diabetes Mellitus has completed, and results were pos…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2019-01-24